Estrella Immunopharma (ESLA) Q4 2024 Earnings

14NovConfirmed
Q4 2024
-0.12
0.21
0.55
0.88

Details

Expected EPS
N/A
Actual EPS
-0.12
Surprise EPS
-0.12
Surprise Percent
+∞%

Description

Estrella Immunopharma (ESLA) has reported earnings of -0.12 per share for Q4 2024.

0 Comments

Share your thoughts